. 2022 Nov 11;65(22):15416–15432. doi: 10.1021/acs.jmedchem.2c01357
© 2022 The Authors. Published by American Chemical Society
Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/).
Figure 10.
Follow-up of FL33 against ATAD2.